Rayaldee 30 µg
As listed in the register: Rayaldee 30 µg, Weichkapseln retardiert
30 µg ·
- Prescription only
- Hormones, such as thyroid and steroids
- Active substance
- Calcifediolum
- Made by
- Vifor Fresenius Medical Care Renal Pharma Ltd.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Rayaldee ist zur Behandlung von sekundärem Hyperparathyreoidismus (SHPT) bei Erwachsenen mit chronischer Niereninsuffizienz (CKD) im Stadium 3 oder 4 und 25- Hydroxyvitamin-D-Serumwerten <30 ng/ml indiziert.
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Vifor Fresenius Medical Care Renal Pharma Ltd. |
|---|---|
| Active substance | Calcifediolum |
| Used in | Hormones, such as thyroid and steroids |
| Strength | 30 µg |
| Classification | H05BX05 · Hormones, such as thyroid and steroids |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Rayaldee 30 µg, Weichkapseln retardiert |
| Packs | 30 Kapsel(n) |
| Zulassungsnummer | 67614 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.